Amanta Healthcare Shares Climb 2% Upon Premium Listing: A Comprehensive Overview

Amanta Healthcare, a pharmaceutical firm specialising in sterile liquid medicines and medical devices, made its debut on Dalal Street on September 9. The IPO of the company, which opened on September 1 and closed on September 3, was subscribed an impressive 82 times overall, indicating strong demand from investors.

The fresh issue of 1 crore shares raised Rs 126 crore for the company. Retail investors contributed to a 54.96-times subscription, while qualified institutional buyers (QIBs) accounted for 35.86 times subscription. Non-institutional investors (NIIs) drove massive interest, with a staggering 209.4 times subscription for the Amanta Healthcare IPO till the final day.

This overwhelming response resulted in the share price of Amanta Healthcare listing at Rs 134 on the National Stock Exchange (NSE), a 7% premium over its issue price. On the Bombay Stock Exchange (BSE), the stock traded at Rs 137, showing a 6.3% premium.

The success of the Amanta Healthcare IPO is significant as it was entirely a fresh issue, with no offer for sale component. The company's market capitalization now stands at Rs 527.3 crore.

Amanta Healthcare's IPO grey market premium stood at Rs 9 per share before the listing. The minimum lot size for retail investors for the IPO was 119 shares, costing Rs 14,994.

Amanta Healthcare is a promising addition to the pharmaceutical sector, and its successful debut on Dalal Street is a testament to investor confidence in the company's potential. This information provides an insight into the listing of Amanta Healthcare and its performance on the stock market.